相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Propranolol Promotes Bone Formation and Limits Resorption Through Novel Mechanisms During Anabolic Parathyroid Hormone Treatment in Female C57BL/6J Mice
Annika Treyball et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Effect of verapamil on bone mass, microstructure and mechanical properties in type 2 diabetes mellitus rats
Xiaodan Wu et al.
BMC MUSCULOSKELETAL DISORDERS (2022)
Captopril alleviates glucocorticoid-induced osteonecrosis of the femoral head by mediating the ACE2/Ang-(1-7)/Mas receptor cascade
Xiaohui Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Telmisartan: An angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats
Mohamed Aziz Mahmoud et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2022)
Angiotensin Receptor Blocker is Associated with a Lower Fracture Risk: An Updated Systematic Review and Meta-Analysis
Jing Wu et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2022)
The Effect of the Angiotensin-Converting Enzyme Inhibitor on Bone Health in Castrated Hypertensive Rats Is Mediated via the Kinin-Kallikrein System
Na Zhang et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2022)
Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress
Bingdong Sui et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2022)
Analysis of the prevalence, risk factors, and clinical characteristics of osteoporosis in patients with essential hypertension
Hai-Long Wu et al.
BMC ENDOCRINE DISORDERS (2022)
Myeloid cell-derived catecholamines influence bone turnover and regeneration in mice
Melanie R. Kuhn et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Hip fracture and mortality: study of specific causes of death and risk factors
Montserrat Barcelo et al.
ARCHIVES OF OSTEOPOROSIS (2021)
The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis
Maha Sabry et al.
PLOS ONE (2021)
Spironolactone Attenuates Methylglyoxal-induced Cellular Dysfunction in MC3T3-E1 Osteoblastic Cells
So Young Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
AMLODIPINE ACCELERATES BONE HEALING IN A STABLE CLOSED FEMORAL FRACTURE MODEL IN MICE
M. M. Menger et al.
EUROPEAN CELLS & MATERIALS (2021)
The effects of intraperitoneal metoprolol administration on healing of bone defects in rat tibia: a pilot study
R. Al Alawy et al.
CLINICAL ORAL INVESTIGATIONS (2020)
Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database
Tove Bokrantz et al.
JOURNAL OF HYPERTENSION (2020)
Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway
Shutao Zhang et al.
EXPERIMENTAL CELL RESEARCH (2020)
The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - A population-based cohort study in Taiwan
Yung-Ta Kao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Furosemide administration results in a transient alteration in calcium balance in mature horses
Abby Pritchard et al.
JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION (2020)
Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism
Christian Adolf et al.
ENDOCRINE (2020)
Association between diuretic use and the risk of vertebral fracture after stroke: a population-based retrospective cohort study
Shu-Man Lin et al.
BMC MUSCULOSKELETAL DISORDERS (2019)
The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative
L. D. Carbone et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Thiazide Diuretics and the Incidence of Osteoporotic Fracture: A Systematic Review and Meta-Analysis of Cohort Studies
Jun Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Risk for Hip Fracture due to Alpha Blocker Treatment in Korean Women: National Health Insurance Database Study
Gi H. Seo et al.
LUTS-LOWER URINARY TRACT SYMPTOMS (2018)
Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway
Yan-Zhen Cheng et al.
LIFE SCIENCES (2018)
Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies
X. Xiao et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice
Xiang-Fan Chen et al.
PHARMACOLOGICAL REPORTS (2018)
Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism
Sundeep Khosla et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Thiazide-associated hyponatremia attenuates the fracture-protective effect of thiazide: A population-based study
Lii-Jia Yang et al.
PLOS ONE (2018)
ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men
Timothy Kwok et al.
AGE AND AGEING (2017)
Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies
Setor K. Kunutsor et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized Rats
Benjamin Teong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Number of daily antihypertensive drugs and the risk of osteoporotic fractures in older hypertensive adults: National health insurance service - Senior cohort
So Yeon Kim et al.
JOURNAL OF CARDIOLOGY (2017)
Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system
Kaizhong Yan et al.
MOLECULAR MEDICINE REPORTS (2017)
Meta-analysis of hypertension and osteoporotic fracture risk in women and men
C. Li et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men
Nahid Rianon et al.
ARCHIVES OF OSTEOPOROSIS (2017)
ACE-2/Ang1-7/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats
Hatem M. Abuohashish et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Angiotensin II/Angiotensin II Receptor Blockade Affects Osteoporosis via the AT1/AT2-Mediated cAMP-Dependent PKA Pathway
Yi Zhou et al.
CELLS TISSUES ORGANS (2017)
Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice
Y. Zhang et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Osteogenic actions of metoprolol in an ovariectomized rat model of menopause
Yuan Zang et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2016)
A comparative study between the effect of 17-β estradiol and angiotensin converting enzyme inhibitor on osteoporosis in ovariectomized rats
Mona M. Allam et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2016)
Risk of hip/femur fractures during the initiation period of -adrenoceptor blocker therapy among elderly males: a self-controlled case series study
Chao-Lun Lai et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats
Da Liu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Risk of fractures in subjects with antihypertensive medications: A nationwide claim study
Hyung Jin Choi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Association between loop diuretic use and fracture risk
F. Xiao et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Angiotensin II induces mitochondrial oxidative stress and mtDNA damage in osteoblasts by inhibiting SIRT1-FoxO3a-MnSOD pathway
Yong Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia
Toshio Fumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Low Dose of Propranolol Does Not Affect Rat Osteotomy Healing and Callus Strength
Peter Smitham et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2014)
Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis
Zhang Yongtao et al.
ENDOCRINE (2014)
Noradrenaline stimulates cell proliferation by suppressing potassium channels via Gi/o-protein-coupled 1B-adrenoceptors in human osteoblasts
D. Kodama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Amlodipine Increases Vitamin D Levels More Than Valsartan in Newly Diagnosed Hypertensive Patients: Pointing to an Additional Effect on Bone Metabolism or a Novel Marker of Inflammation?
Seyit Ahmet Ay et al.
RENAL FAILURE (2013)
L-type calcium channels play a crucial role in the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells
Li Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation
W. F. Rodrigues et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese
Ya-feng Zhang et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Alpha-adrenergic blocker mediated osteoblastic stem cell differentiation
Yoon Jung Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Protective effect of amlodipine against osteoporosis in stroke-prone spontaneously hypertensive rats
Kentarou Ushijima et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone
Melita M. Dvorak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study
L Rejnmark et al.
JOURNAL OF HYPERTENSION (2006)
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: Results from a randomized controlled study with bumetanide
L Rejnmark et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Fracture risk in patients treated with loop diuretics
L Rejnmark et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Hyperparathyroidism and the calcium paradox of aldosteronism
VS Chhokar et al.
CIRCULATION (2005)
Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover
L Rejnmark et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Use of β-blockers and risk of fractures
RG Schlienger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Thiazide diuretics and the risk for hip fracture
MWCJ Schoofs et al.
ANNALS OF INTERNAL MEDICINE (2003)
Estimating hip fracture morbidity, mortality and costs
RS Braithwaite et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Use of alpha-blockers and the risk of hip/femur fractures
PC Souverein et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels
G Sigurdsson et al.
JOURNAL OF INTERNAL MEDICINE (2001)
No effect of verapamil on the local bone response to in vivo mechanical loading
E Samnegård et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2001)
Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults - A randomized, double-blind, placebo-controlled trial
AZ LaCroix et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
